Viau S, Fontaine E, Véronneau M, Jasmin G, Dumont L
Département de pharmacologie, Faculté de médecine, Université de Montréal, Québec, Canada.
J Card Fail. 1997 Sep;3(3):207-15. doi: 10.1016/s1071-9164(97)90017-8.
Several studies suggest that coronary perfusion is abnormal in heart failure. The fact that these deficits may results in an altered coronary reserve remains controversial. Therefore, coronary adaptability to short-duration ischemia and the resultant myocardial reactive hyperemia were investigated in a model of chronic heart failure.
Experiments were performed in normal and failing hamster hearts (UM-X7.1, aged > 225 days). Heart rate, left ventricular developed pressure, and coronary flow were recorded continuously before and after each 30-second ischemia in isolated perfused heart preparations. Studies were conducted under control conditions and in the presence of four inhibitors of potential mediators of the reactive hyperemia response: the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (30 microM), the adenosine antagonist 8-(p-sulfophenyl)theophylline (50 microM), the K+ cyclic adenosine triphosphate-dependent channel antagonist glibenclamide (10 microM), and the cyclooxygenase inhibitor indomethacin (10 microM). Baseline hemodynamic parameters were all significantly impaired in failing hearts. Under control conditions, failing hearts were able to respond adequately to a 30-second ischemia: repayment-to-debt ratio averaged 1.02 +/- 0.09 as compared with 1.10 +/- 0.09 in normal hearts (P = NS). All inhibitors significantly reduced basal coronary perfusion except for indomethacin. Of the four inhibitors of potential mediators of the myocardial reactive hyperemic response, only glibenclamide and indomethacin impaired the repayment-to-debt ratio. In their presence, repayment-to-debt ratio was reduced by 40% of the baseline response (P < .01) without significant difference between normal and failing hearts. On the contrary, NG-nitro-L-arginine methyl ester and 8-(p-sulfophenyl)theophylline did not alter the repayment-to-debt ratio.
These observations demonstrate the capacity of the failing heart to tolerate short-duration ischemia despite the presence of significant alterations in its basal coronary perfusion. In addition, results suggest that activation of K+ adenosine triphosphate-dependent channels and the presence of cyclooxygenase by-products are important determinants of coronary adaptation to short-duration ischemia in this model of chronic heart failure.
多项研究表明,心力衰竭时冠状动脉灌注异常。这些缺陷是否会导致冠状动脉储备改变仍存在争议。因此,在慢性心力衰竭模型中研究了冠状动脉对短期缺血的适应性以及由此产生的心肌反应性充血。
在正常和衰竭的仓鼠心脏(UM-X7.1,年龄>225天)上进行实验。在离体灌注心脏标本中,每次30秒缺血前后连续记录心率、左心室舒张末压和冠状动脉血流量。研究在对照条件下以及在存在四种反应性充血反应潜在介质抑制剂的情况下进行:一氧化氮合酶抑制剂NG-硝基-L-精氨酸甲酯(30μM)、腺苷拮抗剂8-(对磺基苯基)茶碱(50μM)、钾离子三磷酸腺苷依赖性通道拮抗剂格列本脲(10μM)和环氧化酶抑制剂吲哚美辛(10μM)。衰竭心脏的基线血流动力学参数均显著受损。在对照条件下,衰竭心脏能够对30秒缺血做出充分反应:偿还与欠债比率平均为1.02±0.09,而正常心脏为1.10±0.09(P=无显著性差异)。除吲哚美辛外,所有抑制剂均显著降低基础冠状动脉灌注。在四种心肌反应性充血反应潜在介质抑制剂中,只有格列本脲和吲哚美辛损害了偿还与欠债比率。在它们存在的情况下,偿还与欠债比率降低至基线反应的40%(P<.01),正常心脏和衰竭心脏之间无显著差异。相反,NG-硝基-L-精氨酸甲酯和8-(对磺基苯基)茶碱未改变偿还与欠债比率。
这些观察结果表明,尽管衰竭心脏的基础冠状动脉灌注存在显著改变,但其仍有能力耐受短期缺血。此外,结果表明,钾离子三磷酸腺苷依赖性通道的激活和环氧化酶副产物的存在是该慢性心力衰竭模型中冠状动脉对短期缺血适应性的重要决定因素。